摘要
Abstract Cholangiocarcinoma (CCA) is a malignant tumour of bile duct epithelial cells with dismal prognosis and rising incidence. Chronic inflammation resulting from liver fluke infection, hepatitis and other inflammatory bowel diseases is a major contributing factor to cholangiocarcinogenesis, likely through accumulation of serial genetic and epigenetic alterations resulting in aberration of oncogenes and tumour suppressors. Recent studies making use of advances in high-throughput genomics have revealed the genetic landscape of CCA, greatly increasing our understanding of its underlying biology. A series of highly recurrent mutations in genes such as TP53, KRAS, SMAD4, BRAF, MLL3, ARID1A, PBRM1 and BAP1, which are known to be involved in cell cycle control, cell signalling pathways and chromatin dynamics, have led to investigations of their roles, through molecular to mouse modelling studies, in cholangiocarcinogenesis. This review focuses on the landscape genetic alterations in CCA and its functional relevance to the formation and progression of CCA.
| 原文 | 英語 |
|---|---|
| 文章編號 | 1327 |
| 頁(從 - 到) | 233-244 |
| 頁數 | 12 |
| 期刊 | Best Practice and Research: Clinical Gastroenterology |
| 卷 | 29 |
| 發行號 | 2 |
| DOIs | |
| 出版品狀態 | 已出版 - 01 04 2015 |
| 對外發佈 | 是 |
文獻附註
Publisher Copyright:© 2015 Elsevier Ltd.
UN SDG
此研究成果有助於以下永續發展目標
-
SDG3 健康與福祉
指紋
深入研究「Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver